Gangloff Scott A.
Insider CIK 1663253 · ONS SVP, Development & Mfrg · AKRO Chief Technology Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 204,616 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 73,700 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 17,784 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 5,088 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 21,263 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-08-15 | 2025-08-19 | 2,600 | — | $0 | 17,784 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-08-15 | 2025-08-19 | 2,600 | $19.62 | $51.0K | 26,351 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2025-06-30 | 2025-07-02 | 299 | $23.87 | $7.1K | 23,751 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-18 | 2025-06-20 | 848 | $54.84 | $46.5K | 23,452 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2024-12-16 | 2024-12-18 | 73,700 | — | $0 | 73,700 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2024-12-16 | 2024-12-18 | 24,300 | — | $0 | 24,300 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2024-04-29 | 2024-05-01 | 225,000 | — | $0 | 225,000 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award | 2016-12-21 | 2016-12-22 | 40,000 | — | $0 | 118,573 | SEC↗ |
| ONS Oncobiologics, Inc. | S Sale | 2016-11-11 | 2016-11-14 | 37,369 | $3.75 | $140.1K | 78,573 | SEC↗ |
| ONS Oncobiologics, Inc. | C Conversion | 2016-11-09 | 2016-11-14 | 115,942 | — | $0 | 0 | SEC↗ |
| ONS Oncobiologics, Inc. | M Exercise | 2016-11-09 | 2016-11-14 | 115,942 | — | $0 | 115,942 | SEC↗ |